On December 20, 2023, Athyrium Capital Management, LP announced that it has had and intends to continue having discussions, from time to time, with management and the board of directors of Biora Therapeutics, Inc., and may engage with other stockholders or securityholders of the Company and other relevant parties, or take other actions concerning, the Company?s business, lines of business, operations, strategy, previously announced restructuring, plans and prospects; any extraordinary corporate transactions (including, but not limited to, a merger, reorganization or liquidation); sales of a material amount of assets or divestitures; a change in the board of directors or management; a material change in the Company?s capitalization, capital structure or dividend policies; other material changes in the Company?s business, lines of business, or corporate structure; or similar actions.